NCTWX Performance — Nicholas II, Inc., Class I
Data updated: 2026-09-22
NCTWX returned +5.84% year to date and +1.96% over one year to Jul 2026. Annualised returns are +5.49% over 3 years and +2.71% over 5 years. The fund trailed its US Mid-Cap Growth category average: $100 invested three years ago grew to $117, against $139 for the category, and to $102 over one year, against $110. Volatility over the past three years was 14.71% a year. In the 12 months to Jul 2026 the fund lost a net $24.3M, and assets reached $941.89M.
NCTWX Growth of $100
What $100 invested in Nicholas II, Inc. grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | NCTWX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $102 | $110 |
| 3 years (Aug 2023 – Jul 2026) | $117 | $139 |
| 5 years (Aug 2021 – Jul 2026) | $114 | $121 |
| Since data start (Jul 2019 – Jul 2026) | $167 | $192 |
NCTWX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.84% |
| 1 year | +1.96% |
| 3 years (annualised) | +5.49% |
| 5 years (annualised) | +2.71% |
NCTWX Annual Returns
Calendar-year total returns of Nicholas II, Inc., compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +5.84% |
| 2025 | −1.23% |
| 2024 | +6.78% |
| 2023 | +19.86% |
| 2022 | −18.00% |
| 2021 | +21.57% |
| 2020 | +15.72% |
| 2019 (Jul–Dec) | +8.29% |
NCTWX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.8% | −1.3% | −8.2% | +3.9% | +2.9% | +3.5% | +3.7% | — | — | — | — | — |
| 2025 | +5.5% | −4.1% | −5.3% | −0.7% | +4.3% | +2.5% | +0.8% | −0.6% | −1.2% | −2.1% | 0.0% | +0.3% |
| 2024 | +0.1% | +5.7% | +2.4% | −6.7% | +0.8% | +1.0% | +2.5% | +0.5% | +1.4% | −0.7% | +7.2% | −6.7% |
| 2023 | +7.0% | −2.1% | +0.9% | −1.8% | +0.2% | +7.1% | +2.2% | −2.3% | −4.8% | −5.2% | +9.8% | +8.5% |
| 2022 | −8.2% | −0.8% | +2.1% | −7.7% | −2.0% | −6.4% | +9.1% | −3.2% | −8.0% | +6.9% | +5.2% | −4.6% |
| 2021 | −1.1% | +2.9% | +3.2% | +6.2% | −0.4% | +1.7% | +3.3% | +2.5% | −4.7% | +5.0% | −3.2% | +4.8% |
| 2020 | −0.2% | −7.6% | −16.9% | +13.1% | +9.0% | +0.5% | +6.2% | +2.0% | −1.6% | −1.4% | +11.0% | +4.4% |
| 2019 | — | — | — | — | — | — | +1.8% | −1.2% | +1.1% | +1.1% | +3.3% | +1.9% |
NCTWX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 14.71%
- 3-year Sharpe ratio: 0.07 (vs 4.5% risk-free rate)
- Best month: +9.78% (Nov 2023)
- Worst month: −8.19% (Mar 2026)
NCTWX Fund Flows
Monthly money in and out of Nicholas II, Inc., from SEC Form N-PORT.
- 12-month net flow: −$24.3M
- 12-month gross sales (incl. reinvestments): $95.3M
- Sales ÷ redemptions: 0.80×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $1.4M | $10.2M | −$8.8M |
| Jun 2026 | $487K | $9.0M | −$8.5M |
| May 2026 | $724K | $12.1M | −$11.3M |
| Apr 2026 | $1.1M | $9.0M | −$7.9M |
| Mar 2026 | $703K | $8.8M | −$8.1M |
| Feb 2026 | $1.0M | $8.5M | −$7.5M |
| Jan 2026 | $3.3M | $10.7M | −$7.4M |
| Dec 2025 | $82.4M | $19.1M | $63.3M |
| Nov 2025 | $1.3M | $7.7M | −$6.5M |
| Oct 2025 | $947K | $12.1M | −$11.1M |
| Sep 2025 | $1.4M | $5.3M | −$3.9M |
| Aug 2025 | $573K | $7.3M | −$6.7M |
NCTWX Assets Under Management
Net assets of Nicholas II, Inc. by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $941.89M |
| 2026-04-30 | $880.69M |
| 2026-01-31 | $960.39M |
| 2025-10-31 | $999.94M |
| 2025-09-30 | $1.03B |
| 2025-06-30 | $1.06B |
| 2025-03-31 | $1.02B |
| 2024-12-31 | $1.08B |
| 2024-09-30 | $1.12B |
| 2024-06-28 | $1.09B |
| 2024-03-31 | $1.16B |
| 2023-12-31 | $1.07B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.